Free Trial

Revolution Medicines (RVMD) Earnings Date, Estimates & Call Transcripts

Revolution Medicines logo
$44.06 +0.77 (+1.78%)
(As of 12/20/2024 05:31 PM ET)

Revolution Medicines Latest Earnings Summary

Actual EPS
(Nov. 6)
-$0.94 Missed By -$0.05
Consensus EPS
(Nov. 6)
-$0.89

Revolution Medicines released Q3 2024 earnings on November 6, 2024, reporting an EPS of -$0.94, which missed analysts' consensus estimates of -$0.89 by $0.05. With a trailing EPS of -$3.59, Revolution Medicines' earnings are expected to decrease next year, from ($3.50) to ($4.00) per share.

Get Revolution Medicines Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Revolution Medicines and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

RVMD Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RVMD Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Revolution Medicines Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20243-$0.77-$0.70-$0.73
Q2 20243-$0.83-$0.73-$0.78
Q3 20243-$0.95-$0.86-$0.90
Q4 20243-$0.98-$0.94-$0.96
FY 202412-$3.53-$3.23-$3.36
Q1 20252-$0.98-$0.92-$0.95
Q2 20252-$1.01-$0.94-$0.98
Q3 20252-$1.04-$0.96-$1.00
Q4 20252-$1.07-$0.97-$1.02
FY 20258($4.10)($3.79)($3.95)

Revolution Medicines Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/6/2024Q3 2024-$0.89-$0.94 -$0.05-$0.94$0.35M-
8/7/2024Q2 2024-$0.77-$0.81 -$0.04-$0.81$0.81M$1.00M
5/8/2024Q1 2024-$0.75-$0.70+$0.05-$0.70$1.37M-
2/26/2024Q4 2023-$0.85-$1.14 -$0.29-$1.14$1.20M$0.74M
11/6/2023Q3 2023-$1.01-$0.99+$0.02-$0.99$0.75M-
8/8/2023Q2 2023-$0.82-$0.92 -$0.10-$0.92$1.56M$3.82M
Trump’s Sending THIS Crypto Higher on Purpose (Ad)

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

5/8/2023Q1 2023-$0.84-$0.72+$0.12-$0.72$2.94M$7.01M
2/27/2023Q4 2022-$0.84-$0.63+$0.21-$0.63$6.75M$15.33M

Revolution Medicines Earnings - Frequently Asked Questions

Revolution Medicines (NASDAQ:RVMD) last announced its quarterly earning data on Wednesday, November 6, 2024. Learn more on RVMD's earnings history.

In the previous quarter, Revolution Medicines (NASDAQ:RVMD) missed the analysts' consensus estimate of ($0.89) by $0.05 with a reported earnings per share (EPS) of ($0.94). Learn more on analysts' earnings estimate vs. RVMD's actual earnings.

The conference call for Revolution Medicines's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Revolution Medicines's latest earnings report can be read online.
Read Transcript

Revolution Medicines (NASDAQ:RVMD) has a recorded annual revenue of $742,000.00.

Revolution Medicines (NASDAQ:RVMD) has a recorded net income of -$436.37 million. RVMD has generated -$3.59 earnings per share over the last four quarters.

Revolution Medicines's earnings are expected to decrease from ($3.50) per share to ($4.00) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:RVMD) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners